Literature DB >> 9194944

Sinusitis in an allergist's office: analysis of 200 consecutive cases.

P A McNally1, M V White, M A Kaliner.   

Abstract

Sinusitis affects up to 14% of Americans. Traditionally, most patients with sinusitis are evaluated and treated by either primary care physicians or otolaryngologists. In order to gain information regarding the characteristics at presentation and the outcome of treatment of sinusitis by an allergist, the records of 200 consecutive patients seen at the Institute for Asthma and Allergy at the Washington Hospital Center for chronic sinusitis were reviewed. The most common presenting symptoms were nasal congestion, postnasal drip, purulent rhinorrhea, headache, cough, facial pressure, anosmia or hyposmia, hypogeusia, and throat clearing. Initial abnormal physical exam findings included abnormal transillumination, purulent secretions, nasal mucosal swelling, nasal polyps, and nasal crusting. Treatment included 4 weeks of oral antibiotics, nasal corticosteroids, nasal lavage, and topical decongestants. All of the presenting symptoms (23-75% of the patients) and signs (50-84% of patients) improved with medical management. Patients have been followed for 1 to 27 months, with a mean of 6 months, and 6% have required surgery, with one complication of cerebrospinal fluid leak. These findings indicate that medical management of chronic sinusitis in an allergist's office is effective.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194944     DOI: 10.2500/108854197778984374

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  13 in total

1.  A survey on chronic rhinosinusitis: opinions from experts of 50 countries.

Authors:  Desiderio Passali; Cemal Cingi; Jacopo Cambi; Francesco Passali; Nuray Bayar Muluk; Maria Luisa Bellussi
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-07       Impact factor: 2.503

2.  Canadian clinical practice guidelines for acute and chronic rhinosinusitis.

Authors:  Martin Desrosiers; Gerald A Evans; Paul K Keith; Erin D Wright; Alan Kaplan; Jacques Bouchard; Anthony Ciavarella; Patrick W Doyle; Amin R Javer; Eric S Leith; Atreyi Mukherji; R Robert Schellenberg; Peter Small; Ian J Witterick
Journal:  Allergy Asthma Clin Immunol       Date:  2011-02-10       Impact factor: 3.406

Review 3.  The Role of IgE Production in the Pathophysiology of Rhinitis and Rhinosinusitis.

Authors:  Elizabeth K Hoddeson; Sarah K Wise
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

Review 4.  Pediatric sinusitis.

Authors:  Ricardo Tan; Sheldon Spector
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

5.  Short-term antibiotics treatment in patients with nasal polyps and enterotoxins producing Staphylococcus aureus strains.

Authors:  Petr Schalek; P Petrás; V Klement; A Hahn
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-22       Impact factor: 2.503

Review 6.  The impact of allergic and nonallergic rhinitis on pediatric sinusitis.

Authors:  Brian A Smart
Journal:  Curr Allergy Asthma Rep       Date:  2006-05       Impact factor: 4.919

Review 7.  Different types of intranasal steroids for chronic rhinosinusitis.

Authors:  Lee Yee Chong; Karen Head; Claire Hopkins; Carl Philpott; Martin J Burton; Anne G M Schilder
Journal:  Cochrane Database Syst Rev       Date:  2016-04-26

8.  Efficacy of medical therapy in treatment of chronic rhinosinusitis.

Authors:  Lee C Young; Nicholas W Stow; Lifeng Zhou; Richard G Douglas
Journal:  Allergy Rhinol (Providence)       Date:  2012-05-18

9.  Nonallergic rhinitis, with a focus on vasomotor rhinitis: clinical importance, differential diagnosis, and effective treatment recommendations.

Authors:  Mark D Scarupa; Michael A Kaliner
Journal:  World Allergy Organ J       Date:  2009-03       Impact factor: 4.084

Review 10.  Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.

Authors:  Lee Yee Chong; Karen Head; Claire Hopkins; Carl Philpott; Anne G M Schilder; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.